Biologic drugs, such as antibodies or recombinant proteins, are characterized by their large, complex, and heterogeneous molecular structure. Given their intricate nature, the development of biologic drugs necessitates a wide array of quantitative tools and accurate models to increase the chances of clinical success.
Human induced pluripotent stem cell (iPSC) technology, coupled with the right assays, is a powerful platform that can utilize early in the discovery of biologic drugs, increasing the confidence on every step of the process.
